Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more
Market Cap & Net Worth: Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ:OACC) has a market capitalization of $211.68 Million ($211.68 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15136 globally and #5980 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's stock price $10.70 by its total outstanding shares 19783010 (19.78 Million).
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Market Cap History: 2025 to 2026
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's market capitalization history from 2025 to 2026. Data shows growth from $209.30 Million to $211.68 Million (0.00% CAGR).
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OACC by Market Capitalization
Companies near Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share in the global market cap rankings as of March 19, 2026.
Key companies related to Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share by market ranking:
- CLUS (PINK:CLUS): Ranked #1958 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8543 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8998 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10627 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1958 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8543 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8998 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30900.00 |
| #10627 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Historical Marketcap From 2025 to 2026
Between 2025 and today, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's market cap moved from $209.30 Million to $ 211.68 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $211.68 Million | +1.13% |
| 2025 | $209.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $211.68 Million USD |
| MoneyControl | $211.68 Million USD |
| MarketWatch | $211.68 Million USD |
| marketcap.company | $211.68 Million USD |
| Reuters | $211.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.